Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans. Circulation. 1995;91(8):2188-2194. 107. Tao W, Deyo DJ, Brunston RL Jr, Vertrees RA, Zwischenberger JB. Extracorporeal heparin adsorption following cardiopulmonary bypass with a heparin removal device an alternative to protamine. Crit Care Med. 1998;26(6):1096-1102. 108. Hulin MS, Wake eld TW, Andrews PC, et al. A novel prot- amine variant reversal of heparin anticoagulation in human blood in vitro. J Vasc Surg. 1997;26(6):1043-1048. 109. Holmer E, Kurachi K, S derstr m G. The molecular- weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem J. 1981;193(2):395-400. 110. Holmer E, S derberg K, Bergqvist D, Lindahl U. Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties. Haemostasis. 1986;16(suppl 2):1-7. 111. Jordan RE, Oosta GM, Gardner WT, Rosenberg RD. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. J Biol Chem. 1980;255(21):10081-10090. 112. Bergqvist D, Nilsson B, Hedner U, Pedersen PC, Ostergaard PB. The effect of heparin fragments of different molec- ular weights on experimental thrombosis and haemostasis. Thromb Res. 1985;38(6):589-601. 113. Carter CJ, Kelton JG, Hirsh J, Cerskus A, Santos AV, Gent M. The relationship between the hemorrhagic and antithrom- botic properties of low molecular weight heparin in rabbits. Blood. 1982;59(6):1239-1245. 114. van Dongen CJ, van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight hep- arins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev. 2004;18(4):CD001100. 115. Bara L, Samama M. Pharmacokinetics of low molecular weight heparins. Acta Chir Scand Suppl. 1988;543:65-72. 116. Bradbrook ID, Magnani HN, Moelker HC, et al. ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man. Br J Clin Pharmacol. 1987;23(6): 667-675. 